Revenue | ₹141.35Cr |
Net Profits | ₹19.73Cr |
Net Profit Margins | 13.96% |
Senores Pharmaceuticals Ltd’s revenue jumped 74.79% since last year same period to ₹141.35Cr in the Q1 2025-2026. On a quarterly growth basis, Senores Pharmaceuticals Ltd has generated 12.2% jump in its revenue since last 3-months.
Senores Pharmaceuticals Ltd’s net profit jumped 83.88% since last year same period to ₹19.73Cr in the Q1 2025-2026. On a quarterly growth basis, Senores Pharmaceuticals Ltd has generated 10.66% jump in its net profits since last 3-months.
Senores Pharmaceuticals Ltd’s net profit margin jumped 5.2% since last year same period to 13.96% in the Q1 2025-2026. On a quarterly growth basis, Senores Pharmaceuticals Ltd has generated -1.38% fall in its net profit margins since last 3-months.
The revenue for Senores Pharmaceuticals Ltd in the Q1 results 2025 was ₹141.35Cr.
The net profit for Senores Pharmaceuticals Ltd in the Q1 results 2025 was ₹19.73Cr.
The net profit margin for Senores Pharmaceuticals Ltd in the Q1 results 2025 was 13.96%.
The revenue for Senores Pharmaceuticals Ltd in the Q1 results 2024 was ₹80.87Cr.
The net profit for Senores Pharmaceuticals Ltd in the Q1 results 2024 was ₹10.73Cr.
The net profit margin for Senores Pharmaceuticals Ltd in the Q1 results 2024 was 13.27%.